Adverts

Open Access Articles- Top Results for Pemtumomab

Pemtumomab

Pemtumomab?
Monoclonal antibody
Source Mouse
Target MUC1
Clinical data
Trade names Theragyn
Intraperitoneal
Identifiers
 7pxY
None
Chemical data
 14pxN (what is this?)  (verify)

Pemtumomab (trade name Theragyn) is a mouse monoclonal antibody used to treat cancer. The substance has affinity to various types of cancer, like ovarian cancer and peritoneal cancer, via the polymorphic epithelial mucin (PEM or MUC-1) and delivers the radioisotope Yttrium-90 into the tumour.[1] As of 2009, it is undergoing Phase III clinical trials.[2]

It has been granted orphan drug status in Europe.[3]

References

  1. ^ Oei, AL; Moreno, M; Verheijen, RH; Sweep, FC; Thomas, CM; Massuger, LF; Von Mensdorff-Pouilly, S (2008). "Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer". International Journal of Cancer. Journal International Du Cancer 123 (8): 1848–53. PMID 18661524. doi:10.1002/ijc.23725. 
  2. ^ ClinicalTrials.gov
  3. ^ Antisoma's Lead Product, Pemtumomab Granted European Orphan Drug Status


Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.